comparemela.com

Latest Breaking News On - Genovis - Page 5 : comparemela.com

Enovis Corporation (NYSE:ENOV) Q3 2023 Earnings Call Transcript

Enovis Corporation (NYSE:ENOV) Q3 2023 Earnings Call Transcript November 7, 2023 Enovis Corporation beats earnings expectations. Reported EPS is $0.56, expectations were $0.53. Operator: Good morning, and welcome to the Enovis’ Third Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation there will be opportunity to […]

Barclays PLC Has $5 90 Million Stake in Enovis Co (NYSE:ENOV)

Barclays PLC boosted its position in shares of Enovis Co. (NYSE:ENOV – Free Report) by 11.3% during the second quarter, HoldingsChannel reports. The institutional investor owned 92,056 shares of the company’s stock after purchasing an additional 9,332 shares during the period. Barclays PLC’s holdings in Enovis were worth $5,902,000 at the end of the most […]

Enovis (NYSE:ENOV) Receives Buy Rating from Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of Enovis (NYSE:ENOV – Free Report) in a research report released on Friday morning, Benzinga reports. The brokerage currently has a $70.00 price objective on the stock. Several other research analysts have also commented on the stock. Roth Mkm started coverage on shares of Enovis […]

Enovis (NYSE:ENOV) Stock Rating Reaffirmed by Needham & Company LLC

Needham & Company LLC reaffirmed their buy rating on shares of Enovis (NYSE:ENOV – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. Needham & Company LLC currently has a $70.00 price objective on the stock. A number of other analysts have also recently commented on ENOV. Roth Mkm assumed […]

Enovis Co (NYSE:ENOV) Receives $68 00 Average Price Target from Brokerages

Shares of Enovis Co. (NYSE:ENOV – Get Free Report) have received a consensus rating of “Buy” from the five analysts that are currently covering the company, Marketbeat.com reports. Five analysts have rated the stock with a buy recommendation. The average 1 year price target among brokerages that have updated their coverage on the stock in […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.